Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery

被引:417
作者
Kayal, S. [1 ]
Ramanujan, R. V. [1 ]
机构
[1] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore
来源
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS | 2010年 / 30卷 / 03期
关键词
Superparamagnetic magnetic nanoparticles; Functionalization; Conjugation; Magnetic drug delivery; MAGNETIC NANOPARTICLES; SUPERPARAMAGNETIC NANOPARTICLES; BIOMEDICAL APPLICATIONS; CANCER-TREATMENT; HYPERTHERMIA; RELEASE; CARRIER; FUNCTIONALIZATION; PRECIPITATION; NANOSPHERES;
D O I
10.1016/j.msec.2010.01.006
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Magnetic drug targeting is a drug delivery system that can be used in locoregional cancer treatment. Coated magnetic particles, called carriers, are very useful for delivering chemotherapeutic drugs. Magnetic carriers were synthesized by coprecipitation of iron oxide followed by coating with polyvinyl alcohol (PVA). Characterization was carried out using X-ray diffraction, TEM, TGA, FTIR and VSM techniques. The magnetic core of the carriers was magnetite (Fe3O4), with average size of 10 nm. The room temperature VSM measurements showed that magnetic particles were superparamagnetic. The amount of PVA bound to the iron oxide nanoparticles were estimated by thermogravimetric analysis (TGA) and the attachment of PVA to the iron oxide nanoparticles was confirmed by FTIR analysis. Doxorubicin (DOX) drug loading and release profiles of PVA coated iron oxide nanoparticles showed that up to 45% of adsorbed drug was released in 80 h, the drug release followed the Fickian diffusion-controlled process. The binding of DOX to the PVA was confirmed by FTIR analysis. The present findings show that DOX loaded PVA coated iron oxide nanoparticles are promising for magnetically targeted drug delivery. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:484 / 490
页数:7
相关论文
共 70 条
[1]  
Alexiou C, 2000, CANCER RES, V60, P6641
[2]   Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting [J].
Alexiou, C ;
Arnold, W ;
Hulin, P ;
Klein, RJ ;
Renz, H ;
Parak, FG ;
Bergemann, C ;
Lübbe, AS .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 2001, 225 (1-2) :187-193
[3]  
Alexiou C., 2001, MAGNETOHYDRODYNAMICS, V37, P318
[4]   Targeting cancer cells: magnetic nanoparticles as drug carriers [J].
Alexiou, Christoph ;
Schmid, Roswitha J. ;
Jurgons, Roland ;
Kremer, Marcus ;
Wanner, Gerhard ;
Bergemann, Christian ;
Huenges, Ernst ;
Nawroth, Thomas ;
Arnold, Wolfgang ;
Parak, Fritz G. .
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2006, 35 (05) :446-450
[5]   Magnetic PNIPA hydrogels for hyperthermia applications in cancer therapy [J].
Ang, K. L. ;
Venkatraman, S. ;
Ramanujan, R. V. .
MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS, 2007, 27 (03) :347-351
[6]  
[Anonymous], 1996, The Iron Oxides
[7]   Sustained release of doxorubicin from zeolite-magnetite nanocomposites prepared by mechanical activation [J].
Arruebo, Manuel ;
Fernandez-Pacheco, Rodrigo ;
Irusta, Silvia ;
Arbiol, Jordi ;
Ibarra, M. Ricardo ;
Santamaria, Jesus .
NANOTECHNOLOGY, 2006, 17 (16) :4057-4064
[8]   SYNTHESIS OF VERY FINE MAGHEMITE PARTICLES [J].
BEE, A ;
MASSART, R ;
NEVEU, S .
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS, 1995, 149 (1-2) :6-9
[9]   Functionalisation of magnetic nanoparticles for applications in biomedicine [J].
Berry, CC ;
Curtis, ASG .
JOURNAL OF PHYSICS D-APPLIED PHYSICS, 2003, 36 (13) :R198-R206
[10]   Novel PVA-based hydrogel microparticles for doxorubicin delivery [J].
Cavalieri, Francesca ;
Chiessi, Ester ;
Villa, Raffaella ;
Vigano, Lucia ;
Zaffaroni, Nadia ;
Telling, Mark F. ;
Paradossi, Gaio .
BIOMACROMOLECULES, 2008, 9 (07) :1967-1973